Abstract:Persons with germline variants in the tumor suppressor gene phosphatase and tensin homolog, PTEN , are molecularly diagnosed with PTEN hamartoma tumor syndrome (PHTS). PHTS confers high risks of specific malignancies, and up to 23% of the patients are diagnosed with autism spectrum disorder (ASD) and/or developmental delay (DD). The accurate prediction of these two seemingly disparate phenotypes (cancer vs . ASD/DD) for PHTS at the individual level remains elusive despite the available statistical prevalence of specific phenotypes of the syndrome at the population level. The pleiotropy of the syndrome may, in part, be due to the alterations of the key multi-functions of PTEN. Maintenance of genome integrity is one of the key biological functions of PTEN, but no integrative studies have been conducted to quantify the DNA damage response (DDR) in individuals with PHTS and to relate to phenotypes and genotypes. In this study, we used 43 PHTS patient-derived lymphoblastoid cell lines (LCLs) to investigate the associations between DDR and PTEN genotypes and/or clinical phenotypes ASD/DD vs . cancer. The dynamics of DDR of γ-irradiated LCLs were analyzed using the exponential decay mathematical model to fit temporal changes in γH2AX levels which report the degree of DNA damage. We found that PTEN nonsense variants are associated with less efficient DNA damage repair ability resulting in higher DNA damage levels at 24 hours after irradiation compared to PTEN missense variants. Regarding PHTS phenotypes, LCLs from PHTS individuals with ASD/DD showed faster DNA damage repairing rate than those from patients without ASD/DD or cancer. We also applied the reaction-diffusion partial differential equation (PDE) mathematical model, a tumor cell growth model with a DNA damage term, to accurately describe the DDR process in the LCLs. For each LCL, we can derive parameters of the PDE. Then we averaged the numerical results by PHTS phenotypes. By performing simple subtraction of two subgroup average results, we found that PHTS-ASD/DD is associated with higher live cell density at lower DNA damage level but lower cell density level at higher DNA damage level compared to LCLs from individuals with PHTS-cancer and PHTS-neither. PTEN is a shared risk gene for both cancer and autism spectrum disorder (ASD) and/or developmental delay (DD). Accurate prediction of the clinical phenotypes of each PTEN hamartoma tumor syndrome (PHTS) individual is still not feasible, though population-level risks of ASD/DD and specific component cancers, including breast cancer and thyroid cancer, have been estimated within PHTS cohorts. In this study we provide insights that PHTS-ASD/DD is associated with faster DNA damage repair rate (half-life of phosphorylated H2A histone family member X, γH2AX, signal over time) and LCLs derived from individuals with PHTS-cancer are related with susceptibility to γ irradiation. PHTS-ASD/DD also showed a higher live cell density when DNA damage was at a low level, and lower live cell density at high DNA damage levels compared to the other PHTS phenotypes. Finally, we provide an innovative way to describe DNA damage response (DDR) in a quantitative and integrative fashion, which is applicable to any type of cells.

Single-cell RNA sequencing of conditional Pten knockout neurons in mice

PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons

Genetic Suppression of Mtor Rescues Synaptic and Social Behavioral Abnormalities in a Mouse Model of Pten Haploinsufficiency.

Cell-type specific defects in PTEN -mutant cortical organoids converge on abnormal circuit activity

Neuropathological signatures revealed by transcriptomic and proteomic analysis in Pten-deficient mouse models

Autism-relevant behaviors are minimally impacted by conditional deletion of Pten in oxytocinergic neurons.

Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated β-Catenin Signaling

Single-Cell full-length Isoform Sequencing Unveils Transcriptional Dysregulation in Autism Spectrum Disorder During Cerebral Cortex Development

Autism‐relevant Behaviors Are Minimally Impacted by Conditional Deletion of Pten in Oxytocinergic Neurons

Transcriptional linkage analysis with in vivo AAV-Perturb-seq

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

Cell-Type-Specific Gene Inactivation and in Situ Restoration Via Recombinase-Based Flipping of Targeted Genomic Region

Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing

Precise and Rapid Validation of Candidate Gene by Allele Specific Knockout With CRISPR/Cas9 in Wild Mice

Defining Specific Cell States of MPTP-Induced Parkinson's Disease by Single-Nucleus RNA Sequencing

A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation

Single-cell, whole-embryo phenotyping of mammalian developmental disorders

Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs

Genetic Background Controls Tumor Development In Pten-Deficient Mice

CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment

Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs . cancer in individuals with germline PTEN variants